FDA panel meets to consider 2 COVID vaccines for young children

An advisory committee at the Food and Drug Administration is expected to review and vote on whether to recommend authorization for Pfizer and Moderna vaccines for kids 6 months to 5 years old.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting